$ANTH Anthera Pharmaceuticals Inc Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anthera Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Anthera Pharmaceuticals Inc. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Anthera Pharmaceuticals Inc Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Bianchi Annette | Director | 0 | 0 | Oct 04 2010 | |||
| Dickinson Klara | Chief Regulatory Officer | 0 | 0 | May 22 2017 | |||
| DZIURZYNSKI BOGDAN | 10,000 | 5,900 | Jun 04 2013 | ||||
| DZIURZYNSKI BOGDAN | Director | 0 | 0 | Apr 03 2012 | |||
| DZIURZYNSKI BOGDAN | Director | 0 | 0 | May 10 2012 | |||
| DZIURZYNSKI BOGDAN | 0 | 0 | May 20 2013 | ||||
| ENGLE STEVEN B | 0 | 0 | Apr 29 2016 | ||||
| ENGLE STEVEN B | 0 | 0 | Jan 02 2015 | ||||
| Fritsch Ursula | VP, Glob. Reg. & Compliance | 83,615 | 49,333 | Jul 02 2010 | |||
| Furse Brent | 0 | 0 | Jan 09 2018 | ||||
| HEALY JAMES | Director | 32,443 | 19,141 | Jan 31 2012 | |||
| HEALY JAMES | 0 | 0 | May 20 2013 | ||||
| HEALY JAMES | Director | 4,092,646 | 2,414,661 | May 10 2012 | |||
| HENNEY CHRISTOPHER S | 0 | 0 | Jan 09 2018 | ||||
| HENNEY CHRISTOPHER S | 0 | 0 | May 20 2013 | ||||
| HENNEY CHRISTOPHER S | 0 | 0 | Jan 02 2015 | ||||
| HENNEY CHRISTOPHER S | Director | 100,000 | 59,000 | Jul 02 2012 | |||
| Hislop Colin | Chief Medical Officer | 19,147 | 11,297 | Feb 16 2016 | |||
| Hislop Colin | Chief Medical Officer | 84,959 | 50,126 | Jan 07 2013 | |||
| Hislop Colin | Chief Medical Officer | 24,147 | 14,247 | Jan 02 2015 | |||
| KILFOIL GEORGINA | SVP, Prod. Dev. & Project Mngm | 16,875 | 9,956 | Jul 05 2011 | |||
| KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | 30,035 | 17,721 | Jan 07 2013 | |||
| KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | 24,601 | 14,515 | Jul 03 2012 | |||
| Lau Stephen | VP, Corp. & Business Dev. | 7,000 | 4,130 | Jul 02 2010 | |||
| Leheny A. Rachel | Director | 1,423,896 | 840,099 | Oct 04 2010 | |||
| LIU MAY | Principal Accounting Officer | 7,302 | 4,308 | Jan 09 2018 | |||
| LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | 46,151 | 27,229 | Nov 04 2011 | |||
| LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | 31,151 | 18,379 | Apr 03 2012 | |||
| LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | 41,336 | 24,388 | Jan 07 2013 | |||
| LOWE CHRISTOPHER P. | CFO and Chief Business Officer | 108,915 | 64,260 | May 21 2013 | |||
| Mueller Brian | 10,000 | 5,900 | Jan 09 2018 | ||||
| Mueller Brian | 0 | 0 | Aug 04 2014 | ||||
| Mueller Brian | 0 | 0 | Jan 02 2015 | ||||
| ODINK DEBRA | Chief Technology Officer | 7,896 | 4,659 | Oct 13 2015 | |||
| ODINK DEBRA | Chief Technology Officer | 31,812 | 18,769 | Jan 07 2013 | |||
| ODINK DEBRA | Chief Technology Officer | 13,855 | 8,174 | Jan 02 2015 | |||
| Olson Charles V | Chief Technology Officer | 0 | 0 | May 22 2017 | |||
| ORBIMED ADVISORS LLC | Director | 7,462,000 | 4,402,580 | Feb 01 2013 | |||
| ORBIMED ADVISORS LLC | Director | 2,831,800 | 1,670,762 | Dec 13 2011 | |||
| ORBIMED ADVISORS LLC | 10% Owner | 3,449,734 | 2,035,343 | Oct 04 2010 | |||
| ORBIMED ADVISORS LLC | Director | 0 | 0 | May 27 2011 | |||
| Sager Philip | 0 | 0 | Jan 09 2018 | ||||
| Sager Philip | 0 | 0 | Jun 16 2014 | ||||
| Sager Philip | 0 | 0 | Jan 02 2015 | ||||
| Santel Donald J | Director | 0 | 0 | Jul 05 2011 | |||
| SHANAHAN WILLIAM R JR | Chief Medical Officer | 0 | 0 | Jan 09 2018 | |||
| Sofinnova Management VI, L.L.C. | 10% Owner | 4,072,203 | 2,402,600 | Mar 08 2010 | |||
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 3,983,230 | 2,350,106 | Mar 08 2010 | |||
| SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | 44,969 | 26,532 | Jan 03 2012 | |||
| SPIEGELMAN DANIEL K | 0 | 0 | May 20 2013 | ||||
| SPIEGELMAN DANIEL K | 0 | 0 | Jun 16 2014 | ||||
| SPIEGELMAN DANIEL K | Director | 0 | 0 | May 10 2012 | |||
| Thompson David E. | Director | 7,758 | 4,577 | Jan 09 2018 | |||
| Thompson David E. | 128,201 | 75,639 | Jun 26 2013 | ||||
| Thompson David E. | 0 | 0 | Jan 02 2015 | ||||
| THOMPSON JOHN CRAIG | President & CEO | 19,848 | 11,710 | Jan 09 2018 | |||
| Thompson Peter A. | Director | 0 | 0 | May 10 2012 | |||
| Trias Joaquim | Sr. VP, Preclinical Developmen | 198,546 | 117,142 | Sep 23 2010 | |||
| TRUEX PAUL F | Executive Chaiman | 16,793 | 9,908 | Jan 09 2018 | |||
| TRUEX PAUL F | President and CEO | 645,125 | 380,624 | Jul 02 2012 | |||
| TRUEX PAUL F | President and CEO | 637,125 | 375,904 | Oct 25 2011 | |||
| TRUEX PAUL F | President and CEO | 691,537 | 408,007 | Jan 08 2013 | |||
| TRUEX PAUL F | President and CEO | 89,337 | 52,709 | Jan 02 2015 | |||
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 5,357,528 | 3,160,942 | Jul 11 2011 | |||
| VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | 20,739 | 12,236 | Oct 04 2010 | |||
| ZWEIFACH SANFORD S | 0 | 0 | May 22 2015 | ||||
| ZWEIFACH SANFORD S | 0 | 0 | May 20 2013 | ||||
| ZWEIFACH SANFORD S | 0 | 0 | Jan 02 2015 |